The U.S. Food and Drug Administration (FDA) has announced significant advancements in medical treatments, including the ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

As Trump seeks to purge the federal workforce, employees responsible for researching diseases, inspecting food and ...

Interest in human use of ivermectin grew when people began taking it to prevent or treat COVID-19, despite the FDA and other ...

Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...

Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

HHS is one of the government's costliest federal agencies, with an annual budget of about $1.7 trillion, mostly going to ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...

PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...

Collegium Pharmaceutical is executing on commercializing its drugs and growing sales. Click here to find out why COLL stock ...